BioXcel Therapeutics
BTAI
#9631
Rank
โ‚ฌ20.87 M
Marketcap
0,49ย โ‚ฌ
Share price
-10.80%
Change (1 day)
-86.08%
Change (1 year)

EPS for BioXcel Therapeutics (BTAI)

EPS in 2023 (TTM): -6,70ย โ‚ฌ

According to BioXcel Therapeutics's latest financial reports the company's current EPS (TTM) is -6,82ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -5,67ย โ‚ฌ a decrease over its 2021 EPS that were of -3,91ย โ‚ฌ.

EPS history for BioXcel Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-6,70ย โ‚ฌ18.24%
2022-5,67ย โ‚ฌ44.85%
2021-3,91ย โ‚ฌ7.65%
2020-3,64ย โ‚ฌ87.62%
2019-1,94ย โ‚ฌ51.88%
2018-1,28ย โ‚ฌ350.92%
2017-0,28ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,09ย โ‚ฌ-69.34%๐Ÿ‡บ๐Ÿ‡ธ USA